Skip to content

MIF-1 (Pro-Leu-Gly-NH2) studies: 89 papers with results

Page 2 of 2

  1. Prolyl-leucyl-glycinamide shares some effects with oxytocin but decreases oxytocin levels.

    Petersson M · Physiology & behavior · 2004

    Animal study (in vivo) · rat · 8 results

  2. Antiamnesic effects of D-pipecolic acid and analogues of Pro-Leu-Gly-NH2 in rats.

    Kovács GL · Pharmacology, biochemistry, and behavior · 1988

    Animal study (in vivo) · rat · 2 results

  3. Effect of prolyl-leucyl-glycinamide on blood pressure, heart rate and angiotensin converting enzyme activity in spontaneously hypertensive and Wistar-Kyoto normotensive rats.

    Das S · General pharmacology · 1985

    Animal study (in vivo) · rat · 10 results

  4. Effect of chronic treatment with morphine on the binding of 3H-N-n-propylnorapomorphine to striatal membranes of rats: influence of prolyl-leucyl-glycinamide.

    Das S · Pharmacology · 1985

    Animal study (in vivo) · rat · 3 results

  5. MIF-1: effects on norepinephrine, dopamine and serotonin metabolism in certain discrete brain regions.

    Singhal RL · Pharmacology, biochemistry, and behavior · 1982

    Animal study (in vivo) · rat · 21 results

  6. PLG regulates hnRNP-L expression in the rat striatum and pre-frontal cortex: identification by ddPCR.

    Costain WJ · Peptides · 2003

    Animal study (in vivo) · rat · 5 results

  7. Prolyl-leucyl-glycinamide, thyrotropin-releasing hormone and beta-endorphin-(10-16), like antidepressants, antagonize melatonin-induced behavioural changes in rats.

    Hatta K · European journal of pharmacology · 1995

    Animal study (in vivo) · rat · 1 result

  8. MIF-1 fails to modify agonist-induced oral activity in neonatal 6-OHDA-treated rats.

    Gong L · Peptides · 1993

    Animal study (in vivo) · rat · 4 results

  9. The effects of MIF-I, beta-endorphin and alpha-MSH on d-amphetamine induced paradoxical behavioral thermoregulation: possible involvement of the dopaminergic system.

    Yehuda S · Peptides · 1985

    Animal study (in vivo) · rat · 2 results

  10. Dose-related effect of the oxytocin fragment (prolyl-leucyl-glycinamide) on ?-MPT-induced catecholamine disappearance and serotonin level in rat brain.

    Szabó G · Neurochemistry international · 1981

    Animal study (in vivo) · rat · 8 results

  11. Effects of the oxytocin fragment prolyl-leucyl-glycinamide on sexual behavior in the rat.

    Gorzalka BB · Pharmacology, biochemistry, and behavior · 1991

    Animal study (in vivo) · rat · 5 results

  12. Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat.

    Kostrzewa RM · Neuropharmacology · 1989

    Animal study (in vivo) · rat · 5 results

  13. Neuropeptides related to neurohypophyseal hormones interfere with apomorphine-induced behavioral changes.

    Xiao XS · Neuropeptides · 1984

    Animal study (in vivo) · rat · 7 results

  14. Intensification and attenuation of morphine dependence by D-aspartic acid and PLG.

    Koyuncuoğlu H · Pharmacology, biochemistry, and behavior · 1990

    Animal study (in vivo) · mouse and rat · 3 results

  15. Prolyl-leucyl-glycinamide (PLG): inhibition of offensive aggression in mice.

    Kavaliers M · Life sciences · 1986

    Animal study (in vivo) · mouse · 4 results

  16. Hypothalamic peptide hormone, prolyl-leucyl-glycinamide and analog, inhibit tolerance to the analgesic and locomotor depressant but not to the locomotor stimulant effects of morphine in the mouse.

    Bhargava HN · Neuropharmacology · 1982

    Animal study (in vivo) · mouse · 3 results

  17. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.

    Chiu S · Naunyn-Schmiedeberg's archives of pharmacology · 1980

    Animal study (in vivo) · rat · 1 result

  18. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on morphine-induced antinociception and brain mu, delta and kappa opiate receptors.

    Bhargava HN · Life sciences · 1983

    Animal study (in vivo) · mouse · 4 results

  19. Effects of neurohypophyseal hormones on food-reinforced classical conditioning in the rat.

    Ibragimov RS · Acta physiologica Hungarica · 1988

    Animal study (in vivo) · rat · 4 results

  20. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.

    Pillai NP · Pharmacology, biochemistry, and behavior · 1984

    Animal study (in vivo) · mouse · 4 results

  21. Central action of melanostatin (MIF-1) in mice.

    Brus R · Acta physiologica Polonica · 1984

    Animal study (in vivo) · mouse · 5 results

  22. The action of prolyl-leucyl-glycinamide (PLG) on the nigrostriatal pathway of the rat.

    Pereira JS · Arquivos de neuro-psiquiatria · 1990

    Animal study (in vivo) · rat · 3 results

  23. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum].

    Sheng JG · Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry · 1989

    Animal study (in vivo) · mouse · 2 results

  24. Effect on brain monoamines in the rat of substituted and protected analogues of the oxytocin fragment, prolyl-leucyl-glycinamide following N-terminal substitution by homoproline.

    Szabó G · Acta physiologica Hungarica · 1983

    Animal study (in vivo) · rat · 3 results

  25. Neurohypophysial peptides and the hippocampus. II. Excitation of rat hippocampal neurones by oxytocin and vasopressin applied in vitro.

    Tiberiis BE · Neuropeptides · 1983

    Ex vivo tissue · rat · 10 results

  26. Control of bioactive corticotropin release from the neuro-intermediate lobe of the rat pituitary in vitro.

    Fischer JL · Endocrinology · 1977

    Ex vivo tissue · rat · 2 results

  27. alpha-MSH and Pro-Leu-Gly-NH2 (PLG; MIF-1): influence on dopamine (DA) uptake in crude synaptosomal preparations from rat mediobasal hypothalamus (MBH) and caudate putamen (CP).

    Torre E · Peptides · 1984

    Ex vivo tissue · rat · 2 results

  28. Modulation of agonist stimulated adenylyl cyclase and GTPase activity by L-pro-L-leu-glycinamide and its peptidomimetic analogue in rat striatal membranes.

    Mishra RK · Neuroscience letters · 1999

    Ex vivo tissue · rat · 2 results

  29. Inhibition by L-prolyl-L-leucyl-glycinamide (PLG) of alpha-melanocyte stimulating hormone release from hypothalamic slices.

    Scimonelli T · Peptides · 1982

    Ex vivo tissue · rat · 4 results

  30. Effects of melanostatine (MIF-1) on focal potentials in slices of rat brain cortex.

    Mokrushin AA · Neuropeptides · 1991

    Ex vivo tissue · rat · 6 results

  31. PLGamide characterization and role in osmoregulation in leech brain.

    Salzet M · Brain research. Molecular brain research · 2000

    Ex vivo tissue · leech · 7 results

  32. Synthesis, Pharmacological, and Biological Evaluation of MIF-1 Picolinoyl Peptidomimetics as Positive Allosteric Modulators of D2R.

    Sampaio-Dias IE · ACS chemical neuroscience · 2019

    In vitro (cells) · 4 results

  33. Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors.

    Silva-Reis SC · ACS medicinal chemistry letters · 2023

    In vitro (cells) · 2 results

  34. Proline Homologation in Melanostatin Neuropeptide: Discovery of Potent Modulators of the Dopamine D2 Receptors.

    Sampaio-Dias IE · ACS medicinal chemistry letters · 2025

    In vitro (cells) · 1 result

  35. Discovery of bridged melanostatin derivatives as potent allosteric modulators of the dopamine D2 receptors with improved permeability.

    Sampaio-Dias IE · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026

    In vitro (cells) · 2 results

  36. Synthesis, Pharmacological, and Biological Evaluation of 2-Furoyl-Based MIF-1 Peptidomimetics and the Development of a General-Purpose Model for Allosteric Modulators (ALLOPTML).

    Sampaio-Dias IE · ACS chemical neuroscience · 2021

    In vitro (cell-free) · 1 result

  37. Differences in prolyl-leucyl-glycinamide metabolism by hypothalamus, pituitary and cerebral cortex of male and female rats.

    Celis ME · Neurochemistry international · 1982

    In vitro (cell-free) · rat · 9 results

  38. Evaluation of Density Functionals, SCC-DFTB, Neglect of Diatomic Differential Overlap (NDDO) Models and Molecular Mechanics Methods for Prolyl-Leucyl-Glycinamide (PLG) and Structural Derivatives.

    Wood RL · Theochem · 2010

    Not a test of MIF-1 (Pro-Leu-Gly-NH2) alone · 2 results

  39. Possible association of increased rat behavioral effects and increased striatal dopamine and norepinephrine levels during the DOPA-potentiation test.

    Spirtes MA · Pharmacology, biochemistry, and behavior · 1976

    Not a test of MIF-1 (Pro-Leu-Gly-NH2) alone · 1 result

How PepBank reports evidence